Vollmer CM - Search Results

1

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Lau R, Dissette VB, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Among authors: vollmer cm. Cancer Res. 1997 Jul 15;57(14):2865-9. Cancer Res. 1997. PMID: 9230191

2

Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.

Ribas A, Bui LA, Butterfield LH, Vollmer CM, Jilani SM, Dissette VB, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Among authors: vollmer cm. Anticancer Res. 1999 Mar-Apr;19(2A):1165-70. Anticancer Res. 1999. PMID: 10368670

3

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS. Vollmer CM Jr, et al. Cancer Res. 1999 Jul 1;59(13):3064-7. Cancer Res. 1999. PMID: 10397245

4

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: vollmer cm. Cancer Res. 1999 Jul 1;59(13):3134-42. Cancer Res. 1999. PMID: 10397256

5

p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.

Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH, Economou JS. Vollmer CM, et al. Cancer Res. 1999 Sep 1;59(17):4369-74. Cancer Res. 1999. PMID: 10485485

6

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Dissette VB, Koh A, Vollmer CM, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Among authors: vollmer cm. Cancer Gene Ther. 1999 Nov-Dec;6(6):523-36. doi: 10.1038/sj.cgt.7700076. Cancer Gene Ther. 1999. PMID: 10608349

7

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.

Andrews KJ, Ribas A, Butterfield LH, Vollmer CM, Eilber FC, Dissette VB, Nelson SD, Shintaku P, Mekhoubad S, Nakayama T, Taniguchi M, Glaspy JA, McBride WH, Economou JS. Andrews KJ, et al. Among authors: vollmer cm. Cancer Res. 2000 Nov 15;60(22):6457-64. Cancer Res. 2000. PMID: 11103813

8

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB, Faull K, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: vollmer cm. J Immunol. 2001 Apr 15;166(8):5300-8. doi: 10.4049/jimmunol.166.8.5300. J Immunol. 2001. PMID: 11290817

9

Intratumoral rIL2-based immunotherapy in B16 melanoma.

Yeung RS, Vollmer C, Taylor DD, Palazzo J, Weese JL. Yeung RS, et al. J Surg Res. 1992 Aug;53(2):203-10. doi: 10.1016/0022-4804(92)90036-y. J Surg Res. 1992. PMID: 1405610

10

COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective.

Marcum M, Kurtzweil N, Vollmer C, Schmid L, Vollmer A, Kastl A, Acker K, Gulati S, Grover P, Herzog TJ, Ahmad SA, Sohal D, Wise-Draper TM. Marcum M, et al. Cancer Med. 2020 Sep;9(17):6141-6146. doi: 10.1002/cam4.3292. Epub 2020 Jul 10. Cancer Med. 2020. PMID: 32648667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters